Want to see GB:AVG full AI Analyst Report?
Top Page
Avingtrans
(LSE:AVG)
Select Model
Select Model
Rating:67Neutral
Price Target:
694.00 p
▼(-3.61% Downside)
Action:Downgraded
Date:05/09/26
The score is primarily supported by solid financial performance (growth, improving profitability, low leverage, and stronger free cash flow). This is tempered by technical indicators signaling overbought conditions despite a clear uptrend, while valuation is reasonable but not strongly supported by yield.
Positive Factors
Balance sheet strength
Avingtrans's low debt-to-equity (0.23) indicates conservative financing and strong solvency. This durable capital structure preserves flexibility to fund capex, bid on project work, support aftermarket delivery, and withstand cyclical downturns without forcing distressed asset sales.
Negative Factors
Low net margin
Net margin around 4% is modest for an engineering/manufacturing group and leaves limited buffer against cost inflation or contract overruns. Persistent low margin constrains retained earnings for growth, limits pricing power benefits, and heightens sensitivity to margin shocks.
Read all positive and negative factors
Positive Factors
Negative Factors
Balance sheet strength
Avingtrans's low debt-to-equity (0.23) indicates conservative financing and strong solvency. This durable capital structure preserves flexibility to fund capex, bid on project work, support aftermarket delivery, and withstand cyclical downturns without forcing distressed asset sales.
Read all positive factors
Avingtrans (AVG) vs. iShares MSCI United Kingdom ETF (EWC)
Market Cap
£271.44M
Dividend Yield0.69%
Average Volume (3M)107.17K
Price to Earnings (P/E)34.9
Beta (1Y)0.49
Revenue Growth3.36%
EPS Growth63.32%
CountryUK
Employees1,008
SectorIndustrials
Sector Strength72
IndustryIndustrial - Machinery
Share Statistics
EPS (TTM)0.21
Shares Outstanding36,931,072
10 Day Avg. Volume67,277
30 Day Avg. Volume107,171
Financial Highlights & Ratios
PEG Ratio0.25
Price to Book (P/B)1.20
Price to Sales (P/S)0.87
P/FCF Ratio15.42
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.37
Revenue Forecast (FY)£188.00M
Avingtrans Business Overview & Revenue Model
Company Description
Avingtrans plc operates as a global provider of specialized engineered products, integrated systems, and technical services, catering to the energy, healthcare, and infrastructure sectors. The company's operations are structured into three distinc...
How the Company Makes Money
Avingtrans makes money by selling engineered products and associated services across its operating segments. In Energy, revenue is generated from (1) manufacture and sale of specialised equipment used in nuclear and other energy applications (e.g....
Avingtrans Financial Statement Overview
Summary
Income Statement
75
Positive
Balance Sheet
70
Positive
Cash Flow
65
Positive
| Breakdown | TTM | May 2024 | May 2023 | May 2022 | May 2021 | May 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 155.49M | 156.41M | 136.62M | 116.44M | 99.08M | 98.52M |
| Gross Profit | 48.50M | 47.36M | 44.04M | 36.86M | 32.59M | 28.38M |
| EBITDA | 16.70M | 15.75M | 12.54M | 13.20M | 12.02M | 11.03M |
| Net Income | 7.06M | 6.56M | 3.66M | 5.19M | 6.48M | 3.99M |
Balance Sheet | ||||||
| Total Assets | 196.40M | 192.76M | 186.34M | 155.41M | 154.69M | 142.61M |
| Cash, Cash Equivalents and Short-Term Investments | 5.62M | 8.56M | 12.12M | 17.72M | 24.29M | 30.08M |
| Total Debt | 27.28M | 25.47M | 23.96M | 8.58M | 10.96M | 9.80M |
| Total Liabilities | 76.54M | 77.53M | 73.33M | 46.96M | 48.88M | 43.65M |
| Stockholders Equity | 117.28M | 113.14M | 110.44M | 106.04M | 103.82M | 97.30M |
Cash Flow | ||||||
| Free Cash Flow | 11.11M | 8.80M | -11.06M | 985.00K | -1.10M | 4.03M |
| Operating Cash Flow | 14.29M | 11.61M | 1.33M | 9.68M | 3.88M | 6.45M |
| Investing Cash Flow | -14.67M | -14.29M | -13.58M | -12.52M | -9.35M | 24.56M |
| Financing Cash Flow | -4.05M | -436.00K | 6.78M | -3.40M | -371.00K | -5.85M |
Avingtrans Technical Analysis
Positive
720.00
Price Trends
697.00
Positive
665.63
Positive
599.75
Positive
Market Momentum
8.73
Positive
63.47
Neutral
56.67
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:AVG, the sentiment is Positive. The current price of 720 is below the 20-day moving average (MA) of 724.15, above the 50-day MA of 697.00, and above the 200-day MA of 599.75, indicating a bullish trend. The MACD of 8.73 indicates Positive momentum. The RSI at 63.47 is Neutral, neither overbought nor oversold. The STOCH value of 56.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GB:AVG.
Avingtrans Peers Comparison
UnderperformOutperform
Sector (63)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | £129.61M | 17.74 | 5.98% | 5.97% | -2.11% | 80.71% | |
67 Neutral | £271.44M | 34.90 | 6.13% | 0.69% | 3.36% | 63.32% | |
67 Neutral | £1.60B | 27.82 | 9.30% | 2.43% | 1.68% | 111.96% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | £684.13M | 36.94 | 5.79% | 5.02% | -5.58% | -32.73% | |
51 Neutral | £722.52M | -21.30 | -14.17% | ― | 23.20% | 18.73% | |
49 Neutral | £103.00M | -10.89 | -12.67% | 67.42% | 42.24% | -432.88% |
* Industrials Sector Average
GB:AVG
Avingtrans
728.00
272.20
59.72%
GB:BOY
Bodycote
946.00
319.04
50.89%
GB:CGS
Castings
308.00
58.51
23.45%
GB:ITM
ITM Power
106.30
44.30
71.45%
GB:MPAC
Mpac Group PLC
345.00
65.00
23.21%
GB:MGAM
Morgan Advanced Materials
246.00
45.49
22.68%
Avingtrans Corporate Events
Regulatory Filings and Compliance
Avingtrans Executives Exercise Options and Trim Holdings as Share Capital Increases
Neutral
Jul 28, 2026
Avingtrans has reported that Chief Executive Steve McQuillan, Chief Financial Officer Stephen King and Chief Operating Officer Austen Adams exercised options over a combined 439,600 ordinary shares and subsequently sold 397,500 shares at 710 pence...
Business Operations and StrategyPrivate Placements and Financing
Avingtrans raises £21m in oversubscribed share placing to fund Hayward Tyler expansion
Positive
Jul 10, 2026
Avingtrans plc has conditionally raised £21 million through a significantly oversubscribed placing of 3,309,000 new ordinary shares at 630 pence each, matching the prior closing price and representing about 9 per cent of the enlarged share ca...
Business Operations and StrategyPrivate Placements and Financing
Avingtrans Closes Accelerated Bookbuild for Institutional Share Placing
Positive
Jul 10, 2026
Avingtrans PLC, the AIM-listed engineering group, said its accelerated bookbuild for a share placing launched earlier on 10 July has successfully closed, with Singer Capital Markets running the process and participants to be notified of allocation...
Business Operations and StrategyPrivate Placements and Financing
Avingtrans to Raise £21m to Expand U.S. Nuclear Capacity
Positive
Jul 10, 2026
Avingtrans PLC has launched a proposed conditional placing of 3,309,000 new ordinary shares at 630 pence each to raise about £21 million, equivalent to roughly 9.8% of its existing share capital. The placing, which is not underwritten or subj...
Business Operations and StrategyFinancial DisclosuresRegulatory Filings and Compliance
Avingtrans posts in-line FY26 profits as nuclear and imaging wins offset PPP loan repayment
Positive
Jun 24, 2026
Avingtrans said profit for the year to 31 May 2026 will be in line with market expectations, underpinned by strategically significant contract wins in nuclear and infrastructure and growing exposure to adjacent growth sectors. The Advanced Enginee...
Business Operations and StrategyProduct-Related AnnouncementsRegulatory Filings and Compliance
Avingtrans’ Adaptix Wins CE Mark for Ortho350 3D Orthopaedic Imaging System
Positive
May 12, 2026
Avingtrans’ medical imaging subsidiary Adaptix has secured CE certification for its Ortho350 orthopaedic 3D imaging system, a compact, mobile Digital Tomosynthesis platform designed for low-dose, high-resolution extremity scans at the point ...
Regulatory Filings and Compliance
Avingtrans Executives Exercise Options as Share Capital Rises
Positive
Apr 30, 2026
Avingtrans has announced the exercise of 352,750 share options by senior executives, including CEO Steve McQuillan, CFO Stephen King and COO Austen Adams, along with certain other participants. Following these exercises and the corresponding issue...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.